| Announce Date | 02/04/2026 |
| EPS Normalized Actual | $0.71 (Miss by $-0.016) |
| EPS GAAP Actual | $0.71 (Miss by $-0.016) |
| Revenue Actual | $4.41431B |
| Revenue Surprise | Beat by $4414.31M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $12.69458 |
| EPS GAAP Estimate | $12.69458 |
| Revenue Estimate | $4.492574555B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 4.39 | 22.02 | 4.2755 | 4.55381 | 2 |
| Dec 2029 | 62.86 | 1.54 | 61.94799 | 63.82182 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.72 | 0.72 | 4.41431B | 7.22% | 4414.31M |
| FQ3 2025 (Sep 2025) | 0.86 | 0.86 | 4.7057B | 7.25% | 4705.7M |
| FQ2 2025 (Jun 2025) | -7.99 | -7.99 | 4.52506B | 5.59% | 4525.06M |
| FQ1 2025 (Mar 2025) | 9.4 | 9.4 | 4.13692B | 3.88% | 4136.92M |
| FQ4 2024 (Dec 2024) | 9.56 | 9.56 | 4.0956B | 6.44% | 4095.6M |
| FQ3 2024 (Sep 2024) | 11.47 | 11.47 | 4.36444B | 3.69% | 4364.44M |
| FQ2 2024 (Jun 2024) | 10.61 | 10.61 | 4.2722B | 4.76% | 4272.2M |
| FQ1 2024 (Mar 2024) | 9.27 | 9.27 | 3.97624B | 6.75% | 3976.24M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
12.69458
Consensus Revenue Estimates
4.492574555B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.86667 | -- | 0.85127 | 0.88221 | 4 |
| FQ3 2027 (Sep 2027) | 1.03 | -- | 1.0117 | 1.04847 | 4 |
| FQ2 2027 (Jun 2027) | 0.98333 | -- | 0.96586 | 1.00096 | 4 |
| FQ1 2027 (Mar 2027) | 0.8 | -- | 0.78579 | 0.81434 | 4 |
| FQ4 2026 (Oct 2026) | 17.40723 | 95.86 | 16.97747 | 17.65634 | 7 |
| FQ3 2026 (Jul 2026) | 15.70323 | 94.52 | 15.31554 | 15.92795 | 12 |
| FQ2 2026 (Jun 2026) | 0.87398 | 1014.21 | 0.85845 | 0.88965 | 4 |
| FQ1 2026 (Mar 2026) | 12.69458 | 25.95 | 12.56962 | 12.81392 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.89B | -- | 4.83B | 4.96B | 5 |
| FQ3 2027 (Sep 2027) | 5.27B | -- | 5.2B | 5.34B | 9 |
| FQ2 2027 (Jun 2027) | 5.1B | -- | 5.04B | 5.18B | 6 |
| FQ1 2027 (Mar 2027) | 4.7B | -- | 4.63B | 4.76B | 5 |
| FQ4 2026 (Oct 2026) | 5.16B | 14.4 | 5.06B | 5.21B | 7 |
| FQ3 2026 (Jul 2026) | 4.95B | 4.97 | 4.86B | 5.01B | 12 |
| FQ2 2026 (Jun 2026) | 4.83B | 6.36 | 4.77B | 4.9B | 5 |
| FQ1 2026 (Mar 2026) | 4.49B | 7.92 | 4.46B | 4.53B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.72 | 0.72 | 100% | |
| FQ3 2025 (Sep 2025) | 0.86 | 0.86 | 100% | |
| FQ2 2025 (Jun 2025) | -7.99 | -7.99 | 100% | |
| FQ1 2025 (Mar 2025) | 9.4 | 9.4 | 100% | |
| FQ4 2024 (Dec 2024) | 9.56 | 9.56 | 100% | |
| FQ3 2024 (Sep 2024) | 11.47 | 11.47 | 100% | |
| FQ2 2024 (Jun 2024) | 10.61 | 10.61 | 100% | |
| FQ1 2024 (Mar 2024) | 9.27 | 9.27 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $4.41B | $4414.31M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $4.71B | $4705.7M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $4.53B | $4525.06M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $4.14B | $4136.92M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $4.1B | $4095.6M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.36B | $4364.44M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $4.27B | $4272.2M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.98B | $3976.24M | 100% |